Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Maya Ridinger

9PUBLICATIONS

66CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Nov 18, 2025

Targeting PLK1 Reduces MMP10 to Enhance Radiosensitivity in HPV- Head and Neck Cancer.

Julianna Korns, Maria A Lehn, Shreya Shyamsunder

|Jun 26, 2025

Onvansertib-Based Second-Line Therapies in Combination with Gemcitabine and Carboplatin in Patient-Derived Platinum-Resistant Ovarian Carcinomas.

Federica Guffanti, Ilaria Mengoli, Francesca Ricci

|Mar 20, 2025

PLK1 Inhibition Induces Synthetic Lethality in Fanconi Anemia Pathway-Deficient Acute Myeloid Leukemia.

Aditya S Sheth, Ka-Kui Chan, Sheng Liu

|Oct 30, 2024

Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of <i>KRAS</i>-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial.

Daniel H Ahn, Maya Ridinger, Timothy L Cannon

|Oct 16, 2024

PLK1 Inhibitor Onvansertib Enhances the Efficacy of Alpelisib in <i>PIK3CA</i>-Mutated HR-Positive Breast Cancer Resistant to Palbociclib and Endocrine Therapy: Preclinical Insights.

Sreeja Sreekumar, Elodie Montaudon, Davis Klein

|Jul 22, 2024

Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas.

Michela Chiappa, Alessandra Decio, Luca Guarrera

Pageof 2

Frequent Collaborators

4 joint publications

Peter J P Croucher

3 joint publications

Heinz-Josef Lenz

2 joint publications

Andreas Varkaris

2 joint publications

Susan L Dalrymple

2 joint publications

Mannan Nouri

2 joint publications

Afsaneh Barzi

2 joint publications

Steven P Balk

2 joint publications

Daniel H Ahn

2 joint publications

David J Einstein

2 joint publications

John T Isaacs

Frequent Collaborators

4 joint publications

Peter J P Croucher

3 joint publications

Heinz-Josef Lenz

2 joint publications

Andreas Varkaris

2 joint publications

Susan L Dalrymple

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on : Jun 17, 2022

See more related videos

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on : Jun 17, 2022

See more related videos